1. Home
  2. POST vs LEGN Comparison

POST vs LEGN Comparison

Compare POST & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Post Holdings Inc.

POST

Post Holdings Inc.

HOLD

Current Price

$105.60

Market Cap

5.1B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$18.85

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POST
LEGN
Founded
1895
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.9B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
POST
LEGN
Price
$105.60
$18.85
Analyst Decision
Buy
Buy
Analyst Count
6
14
Target Price
$127.33
$63.46
AVG Volume (30 Days)
801.2K
2.1M
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
$8,158,100,000.00
N/A
Revenue This Year
$4.94
$67.56
Revenue Next Year
$0.42
$43.20
P/E Ratio
$61.88
N/A
Revenue Growth
2.97
N/A
52 Week Low
$95.07
$16.24
52 Week High
$119.85
$45.30

Technical Indicators

Market Signals
Indicator
POST
LEGN
Relative Strength Index (RSI) 50.01 50.28
Support Level $102.32 $16.24
Resistance Level $109.31 $23.68
Average True Range (ATR) 2.42 0.87
MACD -0.49 0.10
Stochastic Oscillator 26.74 33.74

Price Performance

Historical Comparison
POST
LEGN

About POST Post Holdings Inc.

Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: